[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2003, Vol. 1 ›› Issue (3): 226-229.doi: 10.3736/jcim20030325

Previous Articles     Next Articles

Progress of research on apoptosis of breast cancer cells

Cui-yan Lv, Xin-yi Chen   

  1. Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine, Beijing 100700, China
  • Received:2003-02-28 Online:2003-09-20 Published:2003-09-20

RichHTML

0

PDF (PC)

743

Cited

8

Like

This article reviewed information related to the apoptosis of breast cancer cells. Breast cancer is a common malignant tumor in women. Apoptosis is related to the response and resistance to treatment in breast cancer. Here we summarized and integrated the data on apoptosis and its role in the development, prognosis, and treatment of breast cancer. Further study on apoptosis in breast cancer can help find more candidates for predictors and indices of response. Such study will also develop treatment regimens that are tailored to individual tumors and thereby maximize survival.

Key words: breast neoplasms, apoptosis, review

CLC Number: 

  • R737.9
[1] McPherson K, Steel CM, Dixon JM . ABC of breast diseases. Breast cancer epidemiology, risk factors, and genetics[J]. BMJ, 2000,321(7261):624-628
doi: 10.1136/bmj.321.7261.624
[2] Reed JC . Dysregulation of apoptosis in cancer[J]. J Clin Oncol, 1999,17(9):2941-2953
doi: 10.1200/JCO.1999.17.9.2941
[3] Tamm I, Schriever F, Dorken B . Apoptosis: implications of basic research for clinical oncology[J]. Lancet Oncol, 2001,2(1):33-42
doi: 10.1016/S1470-2045(00)00193-5 pmid: 11905616
[4] Hickman JA . Apoptosis induced by anticancer drugs[J]. Cancer Metastasis Rev, 1992,11(2):121-139
doi: 10.1007/BF00048059
[5] Verheij M, Bartelink H . Radiation-induced apoptosis[J]. Cell Tissue Res, 2000,301(1):133-142
doi: 10.1007/s004410000188
[6] Ellis PA, Saccani-Jotti G, Clarke R , et al. Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer[J]. Int J Cancer, 1997,72(4):608-613
doi: 10.1002/(ISSN)1097-0215
[7] Kerr JF, Winterford CM, Harmon BV . Apoptosis. Its significance in cancer and cancer therapy[J]. Cancer, 1994,73(8):2013-2026
doi: 10.1002/(ISSN)1097-0142
[8] Gavrieli Y, Sherman Y, Ben-Sasson SA . Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation[J]. J Cell Biol, 1992,119(3):493-501
doi: 10.1083/jcb.119.3.493
[9] Kumar R, Vadlamudi RK, Adam L . Apoptosis in mammary gland and cancer[J]. Endocr Relat Cancer, 2000,7(4):257-269
doi: 10.1677/erc.0.0070257 pmid: 11174847
[10] Anderson TJ . Pathological studies of apoptosis in the normal breast[J]. Endocr Relat Cancer, 1999,6(1):9-12
doi: 10.1677/erc.0.0060009 pmid: 10732779
[11] Kelloff GJ, Sigman CC, Johnson KM , et al. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer[J]. Cancer Epidemiol Biomarkers Prev, 2000,9(2):127-137
doi: 10.1023/A:1008971508040 pmid: 10698472
[12] Gandhi A, Holland PA, Knox WF , et al. Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast[J]. Br J Cancer, 1998,78(6):788-794
doi: 10.1038/bjc.1998.580
[13] Lipponen P, Aaltomaa S, Kosma VM , et al. Apoptosis in breast cancer as related to histopathological characteristics and prognosis[J]. Eur J Cancer, 1994,30A(14):2068-2073
[14] Allan DJ, Howell A, Roberts SA , et al. Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast[J]. J Pathol, 1992,167(1):25-32
doi: 10.1002/(ISSN)1096-9896
[15] 闵大六, 王保太, 孟刚 , 等. 乳腺癌和癌前病变中细胞凋亡及其与bcl-2、PCNA 表达的关系[J]. 临床与实验病理学杂志, 1999,15(2):99-102
doi: 10.3969/j.issn.1001-7399.1999.02.002
[16] Mommers EC, van Diest PJ, Leonhart AM , et al. Balance of cell proliferation and apoptosis in breast carcinogenesis[J]. Breast Cancer Res Treat, 1999,58(2):163-169
doi: 10.1023/A:1006396103777 pmid: 10674882
[17] Bloom HJ, Richardson WW . Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years[J]. Br J Cancer, 1957,11(3):359-377
doi: 10.1038/bjc.1957.43 pmid: 8330330
[18] Berardo MD, Elledge RM, De Moor C , et al. Bcl-2 and apoptosis in lymph node positive breast carcinoma[J]. Cancer, 1998,82(7):1296-1302
doi: 10.1002/(SICI)1097-0142(19980401)82:7<1296::AID-CNCR12>3.0.CO;2-1 pmid: 9529021
[19] Zhang GJ, Kimijima I, Abe R , et al. Apoptotic index correlates to Bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers[J]. Anticancer Res, 1998,18(3B):1989-1998
[20] 高莉, 詹镕洲, 倪灿荣 , 等. 乳腺癌中凋亡与细胞增殖及Rb、Bcl-2、c-myc蛋白表达的关系[J]. 临床与实验病理学杂志, 1999,15(2):95-98
[21] 张平, 王磊, 王春丽 . 细胞凋亡对乳腺癌预后影响的实验研究[J]. 白求恩医科大学学报, 1999,25(4):404-406
doi: 10.3969/j.issn.1671-587X.1999.04.026
[22] De Jong JS, van Diest PJ, Baak JP . Number of apoptotic cells as a prognostic marker in invasive breast cancer[J]. Br J Cancer, 2000,82(2):368-373
doi: 10.1054/bjoc.1999.0928 pmid: 2363300
[23] Gonzalez-Campora R, Galera Ruiz MR, Vazquez Ramirez F , et al. Apoptosis in breast carcinoma[J]. Pathol Res Pract, 2000,196(3):167-174
doi: 10.1016/S0344-0338(00)80097-7
[24] Forrest AP, Levack PA, Chetty U , et al. A human tumour model[J]. Lancet, 1986,2(8511):840-842
[25] Wolff AC, Davidson NE . Primary systemic therapy in operable breast cancer[J]. J Clin Oncol, 2000,18(7):1558-1569
doi: 10.1007/s004320050040 pmid: 10735905
[26] Ellis PA, Smith IE, McCarthy K , et al. Preoperative chemotherapy induces apoptosis in early breast cancer [letter][J]. Lancet, 1997,349(9055):849
doi: 10.1016/S0140-6736(05)61752-7 pmid: 9121265
[27] Ellis PA, Smith IE, Detre S , et al. Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy[J]. Breast Cancer Res Treat, 1998,48(2):107-116
doi: 10.1023/A:1005933815809
[28] 沈镇宙, 邵志敏, 吴炅 . 细胞凋亡及相关基因在乳腺癌预后和化疗敏感性中的研究[J]. 中国肿瘤, 1999,8(1):26-27
[29] Krajewski S, Krajewska M, Turner BC , et al. Prognostic significance of apoptosis regulators in breast cancer[J]. Endocr Relat Cancer, 1999,6(1):29-40
doi: 10.1677/erc.0.0060029
[30] Turner BC, Krajewski S, Krajewska M , et al. BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer[J]. J Clin Oncol, 2001,19(4):992-1000
doi: 10.1200/JCO.2001.19.4.992 pmid: 11181661
[31] 吴炅, 沈镇宙, 邵志敏 . 乳腺癌细胞凋亡及相关基因表达的预后研究[J]. 上海医学, 1999,22(1):27-31
doi: 10.3969/j.issn.0253-9934.1999.01.007
[32] Ferreira CG, Tolis C , Giaccone G.p53 and chemosensitivity[J]. Ann Oncol, 1999,10(9):1011-1021
[33] Bergh J . Clinical studies of p53 in treatment and benefit of breast cancer patients[J]. Endocr Relat Cancer, 1999,6(1):51-59
doi: 10.1677/erc.0.0060051 pmid: 10732788
[34] Hamilton A, Piccart M . The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2[J]. Ann Oncol, 2000,11(6):647-663
doi: 10.1023/A:1008390429428
[35] Aas T, Borresen AL, Geisler S , et al. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients[J]. Nat Med, 1996,2(7):811-814
doi: 10.1038/nm0796-811
[36] 李忠 . 临床中医肿瘤学(第1版)[M]. 沈阳: 辽宁科学技术出版社, 2002,( 第1版):124-125
[37] Teixeira C, Reed JC, Pratt MA . Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells[J]. Cancer Res, 1995,55(17):3902-3907
[38] Simoes-Wust AP, Olie RA, Gautschi O , et al. Bcl-xl antisense treatment induces apoptosis in breast carcinoma cells[J]. Int J Cancer, 2000,87(4):582-590
doi: 10.1002/1097-0215(20000815)87:43.0.CO;2-P pmid: 10918201
[39] 周岱翰 . 临床中医肿瘤学(第1版)[M]. 北京: 人民卫生出版社, 2003,( 第1版):150-151
[1] Avijit Paul, Kausik Bishayee, Samrat Ghosh, Avinaba Mukherjee, Sourav Sikdar, Debrup Chakraborty, Naoual Boujedaini, Anisur Rahman Khuda-Bukhsh. Chelidonine isolated from ethanolic extract of Chelidonium majus promotes apoptosis in HeLa cells through p38-p53 and PI3K/AKT signalling pathways. Journal of Chinese Integrative Medicine, 2012, 10(9): 1025-1038.
[2] Lan He , Dong Li , Ying-sheng Xu. Target points: A discussion on acupuncture treatment of primary trigeminal neuralgia. Journal of Chinese Integrative Medicine, 2012, 10(9): 961-965.
[3] Wei-hua Xu, Ze-huai Wen, Wei-xiong Liang, Qi Wang. A review of research on the development of instruments for therapeutic efficacy evaluation of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(7): 726-737.
[4] Yogesh Bendale, Vineeta Bendale, Saili Paul, Soumya Sundar Bhattacharyya. Green synthesis, characterization and anticancer potential of platinum nanoparticles Bioplatin. Journal of Chinese Integrative Medicine, 2012, 10(6): 681-689.
[5] Daniel A. Weber, Janelle M. Wheat , Geoffrey M. Currie. Cancer stem cells and the impact of Chinese herbs, isolates and other complementary medical botanicals: A review. Journal of Chinese Integrative Medicine, 2012, 10(5): 493-503.
[6] Gerhard Litscher. High-tech acupuncture made in Austria — cerebral circulation. Journal of Chinese Integrative Medicine, 2012, 10(4): 362-368.
[7] Jin-bin Han, Yong-qiang Hua, Lian-yu Chen, Lu-ming Liu . Advances in Smoothened-targeting therapies for pancreatic cancer: Implication for drug discovery from herbal medicines. Journal of Chinese Integrative Medicine, 2012, 10(3): 256-263.
[8] Satish Patel, Vikas Sharma, Nagendra S. Chauhan, Vinod K. Dixit. An updated review on the parasitic herb of Cuscuta reflexa Roxb. Journal of Chinese Integrative Medicine, 2012, 10(3): 249-255.
[9] Zhuo-xin Yang, Peng-dian Chen, Hai-bo Yu, Min Pi, Wen-shu Luo, Yuan-yuan Zhuo . Study strategies for acupuncture treatment of chronic nonbacterial prostatitis. Journal of Chinese Integrative Medicine, 2012, 10(3): 293-297.
[10] Li-xin Ma, Yu-yi Wang, Xin-xue Li, Jian-ping Liu . Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(3): 279-292.
[11] Da-rong Wu . Modern testing theory and its application in the field of health measurement. Journal of Chinese Integrative Medicine, 2012, 10(3): 271-278.
[12] Zheng Ying. Research and application progress of the infrared effects of moxibustion. Journal of Chinese Integrative Medicine, 2012, 10(2): 135-140.
[13] Dhiman Anju, Nanda Arun, Ahmad Sayeed. A recent update in research on the antihepatotoxic potential of medicinal plants. Journal of Chinese Integrative Medicine, 2012, 10(2): 117-127.
[14] Samadder Asmita, Das Jayeeta, Das Sreemanti, Das Durba, De Arnab, Bhadra Kakali, Rahman Khuda-Bukhsh Anisur. Dihydroxy-isosteviol methyl ester of Pulsatilla nigricans extract reduces arsenic-induced DNA damage in testis cells of male mice: Its toxicity, drug-DNA interaction and signaling cascades. Journal of Chinese Integrative Medicine, 2012, 10(12): 1433-1442.
[15] Kumar Dinesh, Kumar Sunil, Taprial Seema, Kashyap Deepak, Kumar Ajay, Prakash Om. A review of chemical and biological profile of genus Michelia. Journal of Chinese Integrative Medicine, 2012, 10(12): 1336-1340.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228
[an error occurred while processing this directive]